Allergan PLC. (AGN) Shares Sold by Virginia Retirement Systems ET AL

Virginia Retirement Systems ET AL cut its position in shares of Allergan PLC. (NYSE:AGN) by 19.9% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,114 shares of the company’s stock after selling 5,000 shares during the period. Virginia Retirement Systems ET AL’s holdings in Allergan PLC. were worth $4,890,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Veritas Asset Management LLP bought a new position in shares of Allergan PLC. in the 1st quarter worth $761,339,000. Iridian Asset Management LLC CT raised its position in shares of Allergan PLC. by 141.3% in the 1st quarter. Iridian Asset Management LLC CT now owns 1,283,833 shares of the company’s stock worth $306,733,000 after acquiring an additional 751,848 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of Allergan PLC. in the 1st quarter worth $124,255,000. Blue Ridge Capital L.L.C. raised its position in shares of Allergan PLC. by 24.1% in the 1st quarter. Blue Ridge Capital L.L.C. now owns 1,909,900 shares of the company’s stock worth $456,313,000 after acquiring an additional 370,400 shares in the last quarter. Finally, Harbour Capital Advisors LLC raised its position in shares of Allergan PLC. by 21,412.3% in the 2nd quarter. Harbour Capital Advisors LLC now owns 345,917 shares of the company’s stock worth $1,423,000 after acquiring an additional 344,309 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Shares of Allergan PLC. (AGN) opened at 231.21 on Wednesday. Allergan PLC. has a 1-year low of $184.50 and a 1-year high of $256.80. The stock has a market cap of $77.29 billion, a P/E ratio of 7.04 and a beta of 1.18. The firm’s 50-day moving average price is $235.09 and its 200 day moving average price is $237.04.

Allergan PLC. (NYSE:AGN) last posted its earnings results on Thursday, August 3rd. The company reported $4.02 EPS for the quarter, topping the Zacks’ consensus estimate of $3.95 by $0.07. Allergan PLC. had a return on equity of 7.37% and a net margin of 79.17%. The business had revenue of $4.01 billion for the quarter, compared to analysts’ expectations of $3.95 billion. During the same quarter in the previous year, the firm earned $3.35 earnings per share. The business’s revenue was up 8.8% compared to the same quarter last year. On average, equities analysts expect that Allergan PLC. will post $16.25 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Friday, August 18th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date of this dividend is Wednesday, August 16th. Allergan PLC.’s dividend payout ratio (DPR) is currently 9.95%.

Several research analysts have recently commented on the company. BidaskClub lowered Allergan PLC. from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. UBS AG reissued an “outperform” rating and issued a $275.00 price target on shares of Allergan PLC. in a research report on Wednesday, August 9th. Wells Fargo & Company reissued an “outperform” rating and issued a $280.00 price target (up from $270.00) on shares of Allergan PLC. in a research report on Wednesday, August 9th. Cantor Fitzgerald reissued a “hold” rating on shares of Allergan PLC. in a research report on Tuesday, August 22nd. Finally, Argus reissued a “buy” rating and issued a $280.00 price target on shares of Allergan PLC. in a research report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $274.69.

COPYRIGHT VIOLATION WARNING: “Allergan PLC. (AGN) Shares Sold by Virginia Retirement Systems ET AL” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/2888014/allergan-plc-agn-shares-sold-by-virginia-retirement-systems-et-al.html.

About Allergan PLC.

Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.

Institutional Ownership by Quarter for Allergan PLC. (NYSE:AGN)

Receive News & Ratings for Allergan PLC. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.